Senior Associate Director Innovation Technology
Boehringer Ingelheim, Connecticut, United States
Jill Steinbach-Rankins, Ph.D. is a Senior Associate Director of Innovation Technology at Boehringer Ingelheim and an Adjunct Prof. of Pharmacology & Toxicology at the University of Louisville. Dr Steinbach-Rankins joined Boehringer-Ingelheim in May 2022, after holding a tenured Associate Professor appointment in Bioengineering. Her academic research focused on the development of polymeric nanoparticles, electrospun fibers, and 3D-bioprints as new multipurpose delivery technologies to enhance delivery and treatment for cancer, viral, and bacterial applications. In industry, she now investigates a variety of external technologies, focused on drug delivery, predictive capabilities, and novel platforms to support Research & Development. She received her Bachelor’s degree in Materials Science Engineering from the University of Illinois Champaign-Urbana, and Master’s degree at Arizona State University, while working full-time in industry. She earned her Ph.D. in Bioengineering (ASU) and was fortunate to conduct her Postdoctoral training at Yale University. She has been honored to receive more than 22 scientific/leadership awards, ~50 domestic/international research awards earned by her trainees, multiple NIH R01s, R21, and other funding opportunities. She currently serves as Chair of the Controlled Release Society, Skin and Mucosal Delivery (SMD) Focus Group and is leading an industry team focused on bridging academic-industry interests in SMD.
Disclosure information not submitted.
Tech Session III: Skin and Mucosal Delivery II
Wednesday, July 16, 2025
10:00 AM - 12:00 PM EDT
